CompletedNot Applicable

A Comparative Study Between Laryngeal Mask Airway and Magensium Sulphate in Attenuating Systemic Stress Response During Emergence of Patients Undergoing Supratentorial Tumours.

Egypt60 participantsStarted 2018-01-19

Plain-language summary

To evaluate the efficacy of replacement of ETT with LMA and administration of Magnesium sulphate at the end of the surgery in attenuating systemic stress response during emergence of patients undergoing supratentorial tumours

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ASA physical status I, II.
✓. Ages between 18 and 60 years.
✓. Body mass index (BMI) \< 30.
✓. Elective surgery

Exclusion criteria

✕. Patients have cardiovascular, pulmonary, renal, hepatic and endocrine diseases.
✕. Patients have any degree of disturbed conscious level.
✕. Ages \<18 or \>60 years.
✕. BMI \>30.
✕. Patients have history of allergy to Magnesium sulphate.
✕. Patients have uncontrolled hypertension during preoperative assessment.
✕. Patients have risk of aspiration (eg. hiatus hernia)
✕. Patients have difficult airway management during intubation with direct laryngoscope or time of intubation \>30 seconds.

What they're measuring

Mean arterial blood presure

Timeframe: 5 minutes from closure of anesthetics until 15 minutes after extubation

Trial details

NCT IDNCT03406403

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-05-31

View on ClinicalTrials.gov More LMA Versus Mgso4 in Attenuating Stress Response During Emergence of Supratentorial Tumours Patients trials